Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Eton Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −5 vs. Q3 2021
- Shares held
- 5.73M
- −231.6K (−3.9%) vs. Q3 2021
- Total value
- $24.1M
- −$5.45M (−18.5%) vs. Q3 2021
- New holders
- 6
- 7 more added
- Sold out
- 11
- 11 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,385,000 | $10.2M | 2.17% | −703,100−22.8% | Reduced |
| Vanguard Group Inc | 878,402 | $3.77M | 0.00% | +11,937+1.4% | Added |
| AWM Investment Company, Inc. | 500,000 | $2.15M | 0.22% | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 449,438 | $1.93M | 2.57% | +449,438 | New |
| BlackRock Inc. | 298,942 | $1.28M | 0.00% | −1,955−0.6% | Reduced |
| Bridgeway Capital Management, LLC | 203,263 | $872.0K | 0.02% | +102,763+102.3% | Added |
| Geode Capital Management, LLC | 175,853 | $754.0K | 0.00% | +18,737+11.9% | Added |
| Marshall Wace, LLP | 92,092 | $395.0K | 0.00% | +92,092 | New |
| Paradigm Capital Management Inc | 90,000 | $386.0K | 0.02% | +90,000 | New |
| State Street Corp | 83,772 | $359.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 79,455 | $341.0K | 0.00% | −270−0.3% | Reduced |
| Blair William & Co | 44,000 | $189.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 42,240 | $182.0K | 0.00% | −20,906−33.1% | Reduced |
| Gsa Capital Partners LLP | 39,817 | $171.0K | 0.02% | −42,497−51.6% | Reduced |
| Group One Trading, L.P. | 38,800 | $166.0K | 0.00% | +24,756+176.3% | Added |
| Northern Trust Corp | 30,355 | $130.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 30,072 | $129.0K | 0.00% | −4,677−13.5% | Reduced |
| Susquehanna Fundamental Investments, LLC | 28,561 | $123.0K | 0.00% | −2,283−7.4% | Reduced |
| Simplex Trading, LLC | 22,642 | $97.0K | 0.00% | +17,406+332.4% | Added |
| Millennium Management LLC | 20,700 | $89.0K | 0.00% | −410−1.9% | Reduced |
| Susquehanna International Group, LLP | 17,593 | $75.0K | 0.00% | −99,900−85.0% | Reduced |
| Chicago Trust Co NA | 16,700 | $72.0K | 0.01% | 00.0% | Unchanged |
| Fifth Third Bancorp | 15,190 | $65.0K | 0.00% | +15,190 | New |
| ExodusPoint Capital Management, LP | 13,212 | $57.0K | 0.00% | +13,212 | New |
| Financial Advisors Network, Inc. | 10,633 | $46.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 4,079 | $17.0K | 0.00% | +4,079 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 708 | $3.04K | 0.00% | −57−7.5% | Reduced |
| Bank of America Corp | 328 | $1.00K | 0.00% | −30,585−98.9% | Reduced |
| Wells Fargo & Company | 124 | $1.00K | 0.00% | +1+0.8% | Added |
| Lindbrook Capital, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 118,525 | – | – | +13,225+12.6% | Added |
| HRT Financial LP | 0 | $0 | 0.00% | −39,012−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −24,206−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −21,517−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −20,829−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −20,446−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,070−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,652−100.0% | Sold out |
| MML Investors Services, LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,382−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,137−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |